Atrial fibrillation trials recruiting in Georgia

All Atrial fibrillation trials nationally

Cities in Georgia

Recruiting trials in Georgia

• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
  NCT06455098 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Georgia: Atlanta, Savannah
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Augusta, Marietta
• Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
  NCT06935591 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Georgia: Athens, Atlanta
• BoxX-NoAF Clinical Trial
  NCT06989775 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · Georgia: Atlanta, Marietta
• Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
  NCT06784466 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Georgia: Atlanta
• Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
  NCT07298473 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Savannah
• DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
  NCT05795842 · Phase: Not specified · Ages: 55 Years and older · Sex: All (male and female) · Georgia: Atlanta
• Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
  NCT07575269 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
  NCT07308847 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Georgia: Savannah
• PULSED AF Post-Approval Study
  NCT06578104 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
  NCT04088071 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Savannah
• Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
  NCT06735534 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Macon, Savannah
• Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
  NCT06436924 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Savannah
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Johns Creek
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Johns Creek
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
  NCT07430956 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Johns Creek
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · Georgia: Lithonia, Macon, Norcross, Suwanee
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
  NCT06324201 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
  NCT05836987 · Phase: Phase 3 · Ages: 22 Years to 85 Years · Sex: All (male and female) · Georgia: Atlanta, Warner Robins